Anti-Angiogenic Drugs: Involvement in Cutaneous Side Effects and Wound-Healing Complication

This is the authors' abstract. We don't add key points for this paper.

Clinicians and surgeons will need to develop management guidelines to optimize patient care to reduce the risk of morbidity. When performing a surgical procedure, the impact of adverse effects from the use of anti-angiogenic drugs should be considered to ensure the welfare of the patient. In addition, the development of more specific inhibitors is necessary to reduce target effects to reduce the occurrence of adverse effects.